^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
VENTANA FOLR1 RxDx Assay

Company:
Roche
Type:
FDA Approved
Related tests:
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay is a qualitative immunohistochemical assay using mouse monoclonal anti-FOLR1, clone FOLR1-2.1, intended for use in the assessment of folate receptor alpha (FOLR1) protein in formalin-fixed, paraffin-embedded epithelial ovarian, fallopian tube, or primary peritoneal cancer tissue specimens by light microscopy. his assay is for use with OptiView DAB IHC Detection Kit for staining on a BenchMark ULTRA instrument. This assay is indicated as an aid in identifying patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer who may be eligible for treatment with ELAHERE (mirvetuximab soravtansine).
Cancer:
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
Gene:
FOLR1 ( Folate receptor alpha )
Drug:
Elahere (mirvetuximab soravtansine-gynx)
Method:
Immunohistochemistry (IHC)
Approvals
Date
Cancer
Gene
Drug
By
Confirmatory trial(s)